Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: A bimodal type of AgPd Plasmonic Blackbody Nanozyme with boosted catalytic efficacy and synergized photothermal therapy for efficacious tumor treatment in the second biological window

Fig. 5

a Schematic illustration of subcellular pathways of AgPd PB nanozyme. b Cell viability of HeLa cells treated with different conditions (Control (1), NIR irradiation (2), AgPd PB (3), AgPd PB + AA + NIR (4) and AgPd PB + NIR (5)) versus the incubated particle concentration (25, 50, 75, 100, 150 and 200 µg·mL-1), mean ± s. d, n = 6. c The mitochondrial potential changes imaged by JC-1 staining under various conditions; Red JC-1 aggregate indicates mitochondria with a normal membrane potential, while the green JC-1 monomer represents the mitochondria with a depolarized membrane. d O2 generation test through catalysis of H2O2 (100 µM in aqueous solution) by AgPd PB nanozyme. e Detection of intracellular ROS after HeLa cells treated with different samples and conditions. f The flow cytometry of Hela cells treated with diverse conditions as that in (b)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us